What is the current Price Target for the Abeona Therapeutics, Inc. stock?

The average Abeona Therapeutics, Inc. target price is $18.20. This is 288.89% higher than the current stock price. The highest price target is 434.19%, the lowest is 199.15%. 5 Analysts have issued a price target Abeona Therapeutics, Inc. 2026 .

How high will the Abeona Therapeutics, Inc. stock rise?

No reliable answer can be given as to how high the Abeona Therapeutics, Inc. stock will rise. The performance of stocks, including the Abeona Therapeutics, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Abeona Therapeutics, Inc. stock today?

The performance of Abeona Therapeutics, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Abeona Therapeutics, Inc. stock fall?

The decline in Abeona Therapeutics, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Abeona Therapeutics, Inc. Forecast, price target & analysts

$4.77

1.88% today

Nasdaq, Apr 03, 06:45 pm CET

ISIN

US00289Y1073

Symbol

ABEO

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Abeona Therapeutics, Inc. Target price 2025 - Analyst rating & recommendation

Abeona Therapeutics, Inc. Classifications & Recommendation:

Buy

100%

Abeona Therapeutics, Inc. Price Target

Target Price	$18.20
Price	$4.68
Potential	288.89% register free of charge
Number of Estimates	5

	5 Analysts have issued a price target Abeona Therapeutics, Inc. 2026 . The average Abeona Therapeutics, Inc. target price is $18.20. This is 288.89% register free of charge higher than the current stock price. The highest price target is $25.00 434.19% register free of charge , the lowest is $14.00 199.15% register free of charge .
	A rating was issued by 5 analysts: 5 Analysts recommend Abeona Therapeutics, Inc. to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Abeona Therapeutics, Inc. stock has an average upside potential 2026 of 288.89% register free of charge . Most analysts recommend the Abeona Therapeutics, Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-1.55	-1.23
	38.74%	20.65%
P/E		negative
EV/Sales		12.96

3 Analysts have issued a Abeona Therapeutics, Inc. forecast for earnings per share. The average Abeona Therapeutics, Inc. EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-1.55	38.74%
2025	$-1.23 20.65% Unlock
2026	$-0.10 91.87% Unlock
2027	$-0.04 60.00% Unlock

Current	-2.08	25.71%
2025	-3.82 83.65% Unlock
2026	-48.41 1,167.28% Unlock
2027	-117.00 141.69% Unlock

Abeona Therapeutics, Inc....

Current Abeona Therapeutics, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 24 2025
Oppenheimer	Locked ➜ Locked	Locked	Mar 05 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Feb 19 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Nov 25 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Oct 31 2024
Cantor Fitzgerald	Locked ➜ Locked	Locked	Oct 29 2024
Cantor Fitzgerald	Locked ➜ Locked	Locked	Sep 20 2024

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 24 2025
Locked Oppenheimer: Locked ➜ Locked	Mar 05 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Feb 19 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Nov 25 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Oct 31 2024
Locked Cantor Fitzgerald: Locked ➜ Locked	Oct 29 2024
Locked Cantor Fitzgerald: Locked ➜ Locked	Sep 20 2024

Discover more stocks with a high price target

Novo Nordisk 75.12%

Coinbase Global, Inc. 71.30%

BioNTech SE - ADR 48.29%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now